Skip to main content
. Author manuscript; available in PMC: 2015 Jul 31.
Published in final edited form as: Mol Cancer Ther. 2012 Feb 16;11(7):1500–1509. doi: 10.1158/1535-7163.MCT-11-0937

Table 1.

List of NCI-60 Cell Lines in Oxaliplatin Sensitivity Predictor with Corresponding Oxaliplatin Sensitivity Values

Cell Line Source GI50 (μM) TGI (μM) LC50 (μM) Classificationa
ADR-RES Ovarian 0.0317 30.4 100 Sensitive
SW-620 Colon 0.0469 83.75 100 Sensitive
RPMI-8226 Leukemia 0.0527 91.2 100 Sensitive
MOLT-4 Leukemia 0.1365 15.63 100 Sensitive
HT29 Colon 0.1754 8.24 72.44 Sensitive
CCRF-CEM Leukemia 0.3499 100 100 Sensitive
HCT-116 Colon 0.3784 100 100 Sensitive
NCI-H460 Lung 0.4355 38.28 100 Sensitive
TK-10 Renal 21.18 73.96 100 Resistant
HOP-92 Lung 25.47 73.96 100 Resistant
NCI-H322M Lung 35.32 100 100 Resistant
HOP-62 Lung 46.13 100 100 Resistant
SK-OV-3 Ovarian 66.22 100 100 Resistant
EKVX Lung 88.72 100 100 Resistant
MDA-MB-231 Breast 100 100 100 Resistant
HS 578T Breast 100 100 100 Resistant
a

Cell lines with a GI50 < 0.5 μM were classified as sensitive; cell lines with a GI50 > 20 μM were classified as resistant.